Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Autoimmun ; 123: 102710, 2021 09.
Article in English | MEDLINE | ID: covidwho-1330939

ABSTRACT

The development of autoimmune diseases has been reported after SARS-CoV-2 infection. Vaccination against SARS-CoV-2 could also trigger auto-immunity, as it has been described with other vaccines. An aberrant immune response induced by molecular mimicry and bystander activation, especially in predisposed individuals, is a potential mechanism. We report the case of a 76-year-old woman with Hashimoto thyroiditis and prior COVID-19 infection who developed severe autoimmune hepatitis (with typical features including strongly positive anti-smooth muscle antibody and markedly elevated immunoglobulins G, as well as typical histological findings) following SARS-CoV-2 vaccination (mRNA-1273 SARS-CoV-2 vaccine, Moderna®). The link between SARS-CoV-2 vaccination and the development of autoimmune diseases needs to be further investigated. Although a causality relationship cannot be proven, caution may be warranted when vaccinating individuals with known autoimmune diseases.


Subject(s)
Autoantibodies/immunology , COVID-19 Vaccines/adverse effects , COVID-19/prevention & control , Hepatitis, Autoimmune/etiology , SARS-CoV-2/immunology , Vaccination/adverse effects , 2019-nCoV Vaccine mRNA-1273 , Aged , Azathioprine/therapeutic use , Carcinoma, Transitional Cell/complications , Causality , Disease Susceptibility , Female , Hashimoto Disease/complications , Hepatitis, Autoimmune/drug therapy , Hepatitis, Autoimmune/immunology , Hepatitis, Autoimmune/pathology , Hepatitis, Chronic/complications , Hepatitis, Chronic/pathology , Humans , Immunocompromised Host , Immunosuppressive Agents/therapeutic use , Prednisolone/therapeutic use , Urinary Bladder Neoplasms/complications
SELECTION OF CITATIONS
SEARCH DETAIL